Cirrhotic Patients Are at Risk for Health Care-Associated Bacterial Infections

被引:221
作者
Merli, Manuela [1 ]
Lucidi, Cristina
Giannelli, Valerio
Giusto, Michela
Riggio, Oliviero
Falcone, Marco [2 ]
Ridola, Lorenzo
Attili, Adolfo Francesco
Venditti, Mario [2 ]
机构
[1] Univ Roma La Sapienza, Dipartimento Med Clin, Div Gastroenterol, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, Dept Infect Dis & Trop Med, I-00185 Rome, Italy
关键词
Sepsis; Survival; Multidrug Resistance; Nutritional Status; LIVER-TRANSPLANTATION; SEVERE SEPSIS; MALNUTRITION; NORFLOXACIN; PROPHYLAXIS; DEFINITION; PREVENTION; MANAGEMENT; MECHANISMS; DIAGNOSIS;
D O I
10.1016/j.cgh.2010.06.024
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS Bacterial infections are a frequent and serious burden among patients with cirrhosis be cause they can further deteriorate liver function We assessed the epidemiology risk factors, and clinical consequences of bacterial infections in hospitalized cirrhotic patients METHODS In a cohort of hospitalized cirrhotic patients (n = 150) referred the a tertiary cat e setting, all episodes of bacterial infections were recorded prospectively Infections were classified as community acquired (CA), health care-associated (HCA), or hospital acquired (HA) Site of infection, charactetistics of bacteria, and prevalence of antibiotic resistance were reported, consequences for liver function and patient survival were evaluated RESULTS Fifty four infections were observed among 50 patients (12 CA, 22 HCA, and 20 HA) Bacterial resistance was more frequent among patients with HCA or HA infections (64% of isolates) Mortality was 37% from HA, 36% from HCA, and 0% from CA infections Independent predictors of Infection Included a previous infection within the past 12 months (P = 0001, 95% confidence interval [CI], 2 2-10 6), model of end stage liver disease store >= 15 (P = 01, 95% CI, 1 3-6 1), and protein malnutrition (P = 04, 95% CI, 1 5-10) Infectious episodes worsened live, function in 62% of patients Patients with infection more frequently developed ascites, hepatic encephalopathy, hyponatamia, hepatorenal syndrome, or septic shock Child class C (P = 006, 95% CI, 1 67-23 7), sepsis (P = 005, 95% CI, 1 7-21 4) and protein malnutrition (P = 001 95% CI 2 8 38 5) increased mortality among patients in the hospital CONCLUSIONS In hospitalized cirrhotic patients, the most frequent infections are HCA and HA, these infections are frequently resistant to antibiotics As infections worsen, liver function deteriorates and mortality increases Cirrhotic patients should be monitored closely for infections
引用
收藏
页码:979 / 985
页数:7
相关论文
共 26 条
[1]   Bacterial infection in patients with advanced cirrhosis:: a multicentre prospective study [J].
Borzio, M ;
Salerno, F ;
Piantoni, L ;
Cazzaniga, M ;
Angeli, P ;
Bissoli, F ;
Boccia, S ;
Colloredo-Mels, G ;
Corigliano, P ;
Fornaciari, G ;
Marenco, G ;
Pistarà, R ;
Salvagnini, M ;
Sangiovanni, A .
DIGESTIVE AND LIVER DISEASE, 2001, 33 (01) :41-48
[2]   Bacterial infection-related morbidity and mortality in cirrhosis [J].
Christou, Leonidas ;
Pappas, Georgios ;
Falagas, Matthew E. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (07) :1510-1517
[3]  
CONN HO, 1977, GASTROENTEROLOGY, V72, P573
[4]   Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 [J].
Dellinger, R. Phillip ;
Levy, Mitchell M. ;
Carlet, Jean M. ;
Bion, Julian ;
Parker, Margaret M. ;
Jaeschke, Roman ;
Reinhart, Konrad ;
Angus, Derek C. ;
Brun-Buisson, Christian ;
Beale, Richard ;
Calandra, Thierty ;
Dhainaut, Jean-Francois ;
Gerlach, Herwig ;
Harvey, Maurene ;
Marini, John J. ;
Marshall, John ;
Ranieri, Marco ;
Ramsay, Graham ;
Sevransky, Jonathan ;
Thompson, B. Taylor ;
Townsend, Sean ;
Vender, Jeffrey S. ;
Zimmerman, Janice L. ;
Vincent, Jean-Louis .
CRITICAL CARE MEDICINE, 2008, 36 (01) :296-327
[5]   The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa [J].
Falagas, Matthew E. ;
Koletsi, Patra K. ;
Bliziotis, Ioannis A. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (12) :1619-1629
[6]   Renal failure and bacterial infections in patients with cirrhosis:: Epidemiology and clinical features [J].
Fasolato, Silvano ;
Angeli, Paolo ;
Dallagnese, Lucia ;
Maresio, Giulio ;
Zola, Erika ;
Mazza, Elena ;
Salinas, Freddy ;
Dona, Silvio ;
Fagiuoli, Stefano ;
Sticca, Antonietta ;
Zanus, Giacomo ;
Cillo, Umberto ;
Frasson, Ilaria ;
Destro, Carla ;
Gatta, Angelo .
HEPATOLOGY, 2007, 45 (01) :223-229
[7]   Bacterial infections in cirrhosis:: Epidemiological changes with invasive procedures and norfloxacin prophylaxis [J].
Fernández, J ;
Navasa, M ;
Gómez, J ;
Colmenero, J ;
Vila, J ;
Arroyo, V ;
Rodés, J .
HEPATOLOGY, 2002, 35 (01) :140-148
[8]   Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage [J].
Fernandez, Javier ;
Del Arbol, Luis Ruiz ;
Gomez, Cristina ;
Durandez, Rosa ;
Serradilla, Regina ;
Guarner, Carlos ;
Planas, Ramon ;
Arroyo, Vicente ;
Navasa, Miguel .
GASTROENTEROLOGY, 2006, 131 (04) :1049-1056
[9]   Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections [J].
Friedman, ND ;
Kaye, KS ;
Stout, JE ;
McGarry, SA ;
Trivette, SL ;
Briggs, JP ;
Lamm, W ;
Clark, C ;
MacFarquhar, J ;
Walton, AL ;
Reller, LB ;
Sexton, DJ .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (10) :791-797
[10]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454